Experimental Factor Ontology (EFO) Information | |
Identifier | EFO_0009640 |
Description | A form of clinicaly history specifically about cancer in family members. | Trait category |
Other trait
|
Synonym | family history of malignant neoplasm |
Mapped term | ICD10:Z80 |
Child trait(s) | 3 child traits |
Polygenic Score ID & Name | PGS Publication ID (PGP) | Reported Trait | Mapped Trait(s) (Ontology) | Number of Variants |
Ancestry distribution GWAS Dev Eval |
Scoring File (FTP Link) |
---|---|---|---|---|---|---|
PGS001292 (GBE_FH1044) |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Family history of prostate cancer | family history of prostate cancer | 602 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS001292/ScoringFiles/PGS001292.txt.gz |
PGS001337 (GBE_FH1002) |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Family history of breast cancer | family history of breast cancer | 195 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS001337/ScoringFiles/PGS001337.txt.gz |
PGS001392 (GBE_FH1001) |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Family history of lung cancer | family history of lung cancer | 312 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS001392/ScoringFiles/PGS001392.txt.gz |
PGS Performance Metric ID (PPM) |
Evaluated Score |
PGS Sample Set ID (PSS) |
Performance Source | Trait |
PGS Effect Sizes (per SD change) |
Classification Metrics | Other Metrics | Covariates Included in the Model |
PGS Performance: Other Relevant Information |
---|---|---|---|---|---|---|---|---|---|
PPM008958 | PGS001292 (GBE_FH1044) |
PSS004039| African Ancestry| 6,497 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Prostate cancer (FH) | — | AUROC: 0.61052 [0.58828, 0.63276] | R²: 0.03568 Incremental AUROC (full-covars): -0.00159 PGS R2 (no covariates): 0.00029 PGS AUROC (no covariates): 0.5142 [0.49179, 0.53661] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM008959 | PGS001292 (GBE_FH1044) |
PSS004040| East Asian Ancestry| 1,704 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Prostate cancer (FH) | — | AUROC: 0.62093 [0.55962, 0.68225] | R²: 0.02796 Incremental AUROC (full-covars): -0.01226 PGS R2 (no covariates): 0.00143 PGS AUROC (no covariates): 0.48253 [0.41865, 0.5464] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM008960 | PGS001292 (GBE_FH1044) |
PSS004041| European Ancestry| 24,905 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Prostate cancer (FH) | — | AUROC: 0.56572 [0.5538, 0.57764] | R²: 0.01155 Incremental AUROC (full-covars): 0.01702 PGS R2 (no covariates): 0.00547 PGS AUROC (no covariates): 0.54869 [0.53677, 0.56062] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM008961 | PGS001292 (GBE_FH1044) |
PSS004042| South Asian Ancestry| 7,831 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Prostate cancer (FH) | — | AUROC: 0.6064 [0.57694, 0.63587] | R²: 0.02296 Incremental AUROC (full-covars): 0.00822 PGS R2 (no covariates): 0.00335 PGS AUROC (no covariates): 0.54379 [0.5154, 0.57217] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM008962 | PGS001292 (GBE_FH1044) |
PSS004043| European Ancestry| 67,425 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Prostate cancer (FH) | — | AUROC: 0.58464 [0.57731, 0.59197] | R²: 0.01828 Incremental AUROC (full-covars): 0.01195 PGS R2 (no covariates): 0.00542 PGS AUROC (no covariates): 0.54716 [0.53996, 0.55435] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM009171 | PGS001337 (GBE_FH1002) |
PSS004034| African Ancestry| 6,497 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Breast cancer (FH) | — | AUROC: 0.57882 [0.5595, 0.59814] | R²: 0.01774 Incremental AUROC (full-covars): 0.00262 PGS R2 (no covariates): 0.00016 PGS AUROC (no covariates): 0.50866 [0.48823, 0.52909] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM009172 | PGS001337 (GBE_FH1002) |
PSS004035| East Asian Ancestry| 1,704 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Breast cancer (FH) | — | AUROC: 0.60865 [0.56929, 0.64801] | R²: 0.03344 Incremental AUROC (full-covars): 0.01456 PGS R2 (no covariates): 0.0091 PGS AUROC (no covariates): 0.56734 [0.52563, 0.60905] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM009173 | PGS001337 (GBE_FH1002) |
PSS004036| European Ancestry| 24,905 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Breast cancer (FH) | — | AUROC: 0.57917 [0.56994, 0.5884] | R²: 0.01887 Incremental AUROC (full-covars): 0.00313 PGS R2 (no covariates): 0.002 PGS AUROC (no covariates): 0.52353 [0.51419, 0.53286] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM009174 | PGS001337 (GBE_FH1002) |
PSS004037| South Asian Ancestry| 7,831 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Breast cancer (FH) | — | AUROC: 0.60464 [0.58531, 0.62397] | R²: 0.02766 Incremental AUROC (full-covars): 0.00261 PGS R2 (no covariates): 0.00157 PGS AUROC (no covariates): 0.52221 [0.5025, 0.54191] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM009175 | PGS001337 (GBE_FH1002) |
PSS004038| European Ancestry| 67,425 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Breast cancer (FH) | — | AUROC: 0.57389 [0.56837, 0.57941] | R²: 0.01618 Incremental AUROC (full-covars): 0.00514 PGS R2 (no covariates): 0.0022 PGS AUROC (no covariates): 0.527 [0.52143, 0.53258] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM005195 | PGS001392 (GBE_FH1001) |
PSS004029| African Ancestry| 6,497 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Lung cancer (FH) | — | AUROC: 0.5814 [0.56522, 0.59758] | R²: 0.02252 Incremental AUROC (full-covars): -0.00177 PGS R2 (no covariates): 0.00021 PGS AUROC (no covariates): 0.49231 [0.47576, 0.50886] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM005196 | PGS001392 (GBE_FH1001) |
PSS004030| East Asian Ancestry| 1,704 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Lung cancer (FH) | — | AUROC: 0.585 [0.55514, 0.61486] | R²: 0.02833 Incremental AUROC (full-covars): -0.00236 PGS R2 (no covariates): 0.00024 PGS AUROC (no covariates): 0.4925 [0.46136, 0.52364] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM005197 | PGS001392 (GBE_FH1001) |
PSS004031| European Ancestry| 24,905 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Lung cancer (FH) | — | AUROC: 0.58684 [0.57949, 0.59418] | R²: 0.02847 Incremental AUROC (full-covars): 0.00084 PGS R2 (no covariates): 0.00154 PGS AUROC (no covariates): 0.51927 [0.51173, 0.52681] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM005198 | PGS001392 (GBE_FH1001) |
PSS004032| South Asian Ancestry| 7,831 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Lung cancer (FH) | — | AUROC: 0.55862 [0.54359, 0.57365] | R²: 0.01079 Incremental AUROC (full-covars): -0.0005 PGS R2 (no covariates): 0.0 PGS AUROC (no covariates): 0.50036 [0.48483, 0.51589] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM005199 | PGS001392 (GBE_FH1001) |
PSS004033| European Ancestry| 67,425 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Lung cancer (FH) | — | AUROC: 0.58081 [0.57641, 0.58522] | R²: 0.02597 Incremental AUROC (full-covars): 0.00042 PGS R2 (no covariates): 0.00043 PGS AUROC (no covariates): 0.51047 [0.50596, 0.51498] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PGS Sample Set ID (PSS) |
Phenotype Definitions and Methods | Participant Follow-up Time | Sample Numbers | Age of Study Participants | Sample Ancestry | Additional Ancestry Description | Cohort(s) | Additional Sample/Cohort Information |
---|---|---|---|---|---|---|---|---|
PSS004029 | — | — | [
|
— | African unspecified | — | UKB | — |
PSS004030 | — | — | [
|
— | East Asian | — | UKB | — |
PSS004031 | — | — | [
|
— | European | non-white British ancestry | UKB | — |
PSS004032 | — | — | [
|
— | South Asian | — | UKB | — |
PSS004033 | — | — | [
|
— | European | white British ancestry | UKB | Testing cohort (heldout set) |
PSS004034 | — | — | [
|
— | African unspecified | — | UKB | — |
PSS004035 | — | — | [
|
— | East Asian | — | UKB | — |
PSS004036 | — | — | [
|
— | European | non-white British ancestry | UKB | — |
PSS004037 | — | — | [
|
— | South Asian | — | UKB | — |
PSS004038 | — | — | [
|
— | European | white British ancestry | UKB | Testing cohort (heldout set) |
PSS004039 | — | — | [
|
— | African unspecified | — | UKB | — |
PSS004040 | — | — | [
|
— | East Asian | — | UKB | — |
PSS004041 | — | — | [
|
— | European | non-white British ancestry | UKB | — |
PSS004042 | — | — | [
|
— | South Asian | — | UKB | — |
PSS004043 | — | — | [
|
— | European | white British ancestry | UKB | Testing cohort (heldout set) |